Literature DB >> 10779586

The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface.

D R Bainbridge1, S A Ellis, I L Sargent.   

Abstract

HLA-G is a nonclassical class I MHC molecule of unknown function expressed on human invasive trophoblast. In trophoblast cells, HLA-G mRNA is alternatively spliced into a variety of forms which are predicted to encode a full length membrane-bound form, three short membrane-bound isoforms and two soluble isoforms. The aim of this study was to determine which of these protein isoforms are translated, which are expressed on the cell surface and which are secreted. Artificial cDNAs encoding the isoforms were generated by PCR mutagenesis, ligated to an epitope tag and transfected into a human cell line capable of expressing MHC class I. Protein products of appropriate sizes were detected in cells transfected with cDNAs encoding all membrane-bound forms, but surface biotinylation studies indicated that only full length membrane-bound HLA-G was present at the cell surface. Full length HLA-G was also detected by surface antibody binding and flow cytometry. Soluble HLA-G1 was detected in cells transfected with the appropriate cDNA only after treatment with monensin, which inhibits transport of glycoproteins through the Golgi apparatus. These results suggest that full length HLA-G, but not short HLA-G isoforms can be expressed on the surface of human cells and that soluble HLA-G is rapidly secreted. Thus, it is likely that the full length membrane-bound and soluble forms of HLA-G are the only biologically active forms to which the mother is exposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779586     DOI: 10.1016/s0165-0378(00)00056-5

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  8 in total

1.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

Authors:  Thomas Vauvert F Hviid; Sine Hylenius; Christina Rørbye; Lone G Nielsen
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

2.  Genotyping: the HLA system and embryo development.

Authors:  Carol M Warner; David A Tyas; Carmit Goldstein; Martina Comiskey; Jacques Cohen; Carol A Brenner
Journal:  Reprod Biomed Online       Date:  2002 Mar-Apr       Impact factor: 3.828

3.  Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions.

Authors:  Michael Eikmans; Carin van der Keur; Jacqueline D H Anholts; Jos J M Drabbels; Els van Beelen; Susana M Chuva de Sousa Lopes; Marie-Louise van der Hoorn
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

4.  The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.

Authors:  Frédéric G Sala; Pierre-Marie Del Moral; Nathalie Pizzato; Florence Legrand-Abravanel; Philippe Le Bouteiller; Françoise Lenfant
Journal:  Immunogenetics       Date:  2004-11-13       Impact factor: 2.846

5.  Variation in the HLA-G promoter region influences miscarriage rates.

Authors:  Carole Ober; Carrie L Aldrich; Inna Chervoneva; Christine Billstrand; Fedik Rahimov; Heather L Gray; Terry Hyslop
Journal:  Am J Hum Genet       Date:  2003-04-29       Impact factor: 11.025

6.  HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation.

Authors:  Josefa A Rodríguez
Journal:  Oncol Lett       Date:  2017-08-21       Impact factor: 2.967

Review 7.  Intercellular transfer of HLA-G: its potential in cancer immunology.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Clin Transl Immunology       Date:  2019-08-30

8.  Effect of extreme conditions of Antarctica on human leukocyte antigen-G in Indian expeditioners.

Authors:  K P Mishra; A P Yadav; Y K Sharma; Lilly Ganju; S B Singh
Journal:  Indian J Med Res       Date:  2014-10       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.